View Older Stories View More Recent Stories
-
Pre-Open Movers 04/20: (IMNP) (SCSS) (KCG) Higher; (PLXS) (WR) (PM) Lower (more...)
-
North American Financial 15 Completes Overnight Offering of $54,110,300
-
Japan's Sawai Pharmaceutical to Acquire the Generics Business of U.S. Upsher-Smith Laboratories
-
AbbVie (ABBV): Pipeline Confidence Weakening - BMO
-
Qualcomm (QCOM) PT Lowered to $54 at BMO Capital
-
After-Hours Stock Movers 04/19: (SCSS) (SLM) (CSX) Higher; (PLXS) (WR) (EBAY) Lower (more...)
-
Whitestone REIT (WSR) Commences 8.1M Share Common Stock Offering
-
Whitestone REIT Announces Proposed Offering of Common Shares
-
Warrior Met Coal Announces Closing of Its Initial Public Offering
-
BMO Capital Reiterates Market Perform Rating and $60 PT on Qualcomm (QCOM) Ahead of 2Q Report Today AMC
-
Anglo Pacific Group PLC: Notification of Transactions by PDMRs
-
Pre-Open Stock Movers 04/19: (ARGS) (CYTR) (IMGN) Higher; (ADPT) (LBY) (IBM) Lower (more...)
-
IBM (IBM) PT Lowered to $165 at BMO Capital
-
Kitware and Newmont Guide Mining with Virtual Reality
-
Dollar rebounds from three-week low; sterling retreats
-
Focus Financial Partners To Receive Significant Investment from Stone Point Capital and KKR
-
After-Hours Stock Movers 04/18: (NVLS) (RARE) (LRCX) Higher; (PLG) (DSX) (IBM) Lower (more...)
-
Platinum Group Metals Ltd. (PLG) Enters Agreement for $20M in Bought Deal Financing
-
Platinum Group Metals Announces US$20 Million Bought Deal Financing
-
BMO Capital Warming to Netflix, Inc. (NFLX)
-
AbbVie (ABBV): Still Concerned About Long Term - BMO
-
Platinum Group Metals Reports Second Quarter 2017 Results
-
ELS Reports First Quarter Results
-
BMO Capital Reiterates Outperform Rating and $73 PT on Alnylam Pharmaceuticals (ALNY); 'Emicizumab Data Does Not Dampen Our Fitusiran Enthusiasm'
-
HighTower Completes $245 Million Financing Transaction to Support Largest-Ever Acquisition
-
BMO Capital Starts Alnylam Pharmaceuticals (ALNY) at Outperform; Revusiran Overhang Clouding Strong Pipeline
-
BMO Capital Downgrades Eli Lilly (LLY) to Underperform; 'Unfavorable Risk/Reward'
-
BMO Capital Starts Halozyme Therapeutics (HALO) at Market Perform
-
Incyte (INCY) PT Lowered to $144 at BMO Capital
-
DAVIDsTEA (DTEA) PT Lowered to $5.50 at BMO Capital Reiterates Market Perform
-
Warrior Met Coal (HCC) IPO Opens 8% Lower
-
Warrior Met Coal Announces Pricing of Its Initial Public Offering
-
BMO Capital Starts RPC Inc. (RES) at Outperform
-
BMO Capital Starts Keane Group (FRAC) at Market Perform
-
BMO Capital Starts Superior Energy Services (SPN) at Market Perform
-
BMO Capital Starts C&J Energy Services (CJ) at Outperform
-
BMO Capital Starts Radient Pharmaceuticals (RPC) at Outperform
-
BlackBerry (BBRY) PT Raised to $9 at BMO Capital Following Announced Arbitration Decision
-
PlacementTracker Publishes Q1 2017 Private Placement Market League Tables
-
Neurocrine (NBIX) Best Case Scenario Plays Out on Ingrezza Label, Sees Upside to >$100 - BMO Capital
-
Whole Foods Market (WFM) PT Raised to $28 at BMO Capital Following Announced Investment by JANA
-
Real Matters Inc. Files Preliminary Prospectus for Initial Public Offering of Common Shares
-
BMO Capital Downgrades OncoMed Pharmaceuticals (OMED) to Market Perform
-
Anglo Pacific Group PLC Notice of 2017 Annual General Meeting
-
EXCO Resources (XCO) to Sell South Texas Properties to KKR (KKR) for $300M
-
EXCO Resources Executes Agreement to Divest South Texas Oil and Natural Gas Properties
-
Red Eagle Mining declares commercial production at the San Ramon Gold Mine and reports 2016 financial results
-
BMO Capital Starts John Bean Technologies (JBT) at Outperform
-
BMO Capital Starts Canada Goose (GOOS) at Outperform
-
BMO Financial Group (BMO) to Name Darryl White as CEO After Bill Downe Retires

